NCT01287403

Brief Summary

Cereal grains contain a wide variety of different phytochemicals which may play different roles in physiology. Their response in plasma and urine after a meal is poorly defined for most cereals. This study will investigate the plasma response and urinary excretion of cereal compounds after eating 6 different types of cereal preparation, with a focus on alkylresorcinols.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Jan 2011

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

January 30, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 1, 2011

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
9 months until next milestone

Results Posted

Study results publicly available

August 14, 2013

Completed
Last Updated

August 31, 2018

Status Verified

August 1, 2018

Enrollment Period

1.6 years

First QC Date

January 30, 2011

Results QC Date

April 9, 2013

Last Update Submit

August 2, 2018

Conditions

Keywords

CerealsAlkylresorcinolsBetainePhenolicsPlasma and urine cereal phytochemicals

Outcome Measures

Primary Outcomes (1)

  • Plasma Alkylresorcinol Compounds

    Area under the curve (AUC) over baseline of alkylresorcinol compounds are measured for the 6 interventional arms. Time points are: t = 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 24 and 48 h after product intake.

    From 0 to 48 h post dose.

Secondary Outcomes (2)

  • Plasma and Urinary Betaine

    From 0 to 48 hours post dose

  • Phenolic Acids

    0-48 h post dose

Study Arms (6)

Refined wheat flour

PLACEBO COMPARATOR

A negative control flour to serve as a reference.

Other: Esterase wholegrain wheat flourOther: Wholegrain wheat flourOther: Liquid whole grain wheat flourOther: Wholegrain barley flourOther: Liquid wholegrain barley flour

Esterase wholegrain wheat flour

ACTIVE COMPARATOR

Wholegrain wheat flour treated with esterases to release phenolics (positive control for phenolic acids)

Other: Refined wheat flourOther: Wholegrain wheat flourOther: Liquid whole grain wheat flourOther: Wholegrain barley flourOther: Liquid wholegrain barley flour

Wholegrain wheat flour

EXPERIMENTAL

Flour with unknown response

Other: Refined wheat flourOther: Esterase wholegrain wheat flourOther: Liquid whole grain wheat flourOther: Wholegrain barley flourOther: Liquid wholegrain barley flour

Liquid whole grain wheat flour

EXPERIMENTAL

Test flour with unknown response.

Other: Refined wheat flourOther: Esterase wholegrain wheat flourOther: Wholegrain wheat flourOther: Wholegrain barley flourOther: Liquid wholegrain barley flour

Wholegrain barley flour

EXPERIMENTAL

Test flour with unknown response.

Other: Refined wheat flourOther: Esterase wholegrain wheat flourOther: Wholegrain wheat flourOther: Liquid whole grain wheat flourOther: Liquid wholegrain barley flour

Liquid wholegrain barley flour

EXPERIMENTAL

Test flour with unknown response.

Other: Refined wheat flourOther: Esterase wholegrain wheat flourOther: Wholegrain wheat flourOther: Liquid whole grain wheat flourOther: Wholegrain barley flour

Interventions

A treated cereal flour mixed with milk.

Esterase wholegrain wheat flourLiquid whole grain wheat flourLiquid wholegrain barley flourWholegrain barley flourWholegrain wheat flour

A treated cereal flour mixed with milk.

Liquid whole grain wheat flourLiquid wholegrain barley flourRefined wheat flourWholegrain barley flourWholegrain wheat flour

A treated cereal flour mixed with milk.

Esterase wholegrain wheat flourLiquid whole grain wheat flourLiquid wholegrain barley flourRefined wheat flourWholegrain barley flour

A treated cereal flour mixed with milk.

Esterase wholegrain wheat flourLiquid wholegrain barley flourRefined wheat flourWholegrain barley flourWholegrain wheat flour

A treated cereal flour mixed with milk.

Esterase wholegrain wheat flourLiquid whole grain wheat flourLiquid wholegrain barley flourRefined wheat flourWholegrain wheat flour

A treated cereal flour mixed with milk.

Esterase wholegrain wheat flourLiquid whole grain wheat flourRefined wheat flourWholegrain barley flourWholegrain wheat flour

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy
  • Normal-overweight (BMI 19-28 kg/m2)
  • Non-smokers

You may not qualify if:

  • Regular consumers of wholegrain cereals
  • Allergy to cereal or milk products

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NESTEC / Clinical Development Unit / Metabolic Unit

Lausanne, Canton of Vaud, 1000, Switzerland

Location

Results Point of Contact

Title
Dr Maurice Beaumont, MD, PhD
Organization
Clinical Development Unit / Metabolic Unit

Study Officials

  • Alastair B Ross, PhD

    Société des Produits Nestlé (SPN)

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

January 30, 2011

First Posted

February 1, 2011

Study Start

January 1, 2011

Primary Completion

August 1, 2012

Study Completion

December 1, 2012

Last Updated

August 31, 2018

Results First Posted

August 14, 2013

Record last verified: 2018-08

Locations